📅 PUBMED DAILY TRIAGE — 2026-11-16 Window: 2026-11-15T00:00:00Z → 2026-11-16T23:59:59Z (CRDT) Topics scanned: 10 | Articles reviewed: 62 | Candidates evaluated: 65 High priority: 14 | Standard: 24 | Low/archive: 0 | Unsolicited finds: 9 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
43034616 · Prognostic value of circulating cell-free Epstein-Barr virus DNA CpG methylation in extranodal NK/T cell lymphoma. · 6/10 · Integrating it into the prognostic index of natural killer cell lymphoma (PINK) model created PINK-CpGE, which showed improved predictive accuracy (AUC 09333 vs
CBC-based diagnostics and machine learning in hematology
CBC-based diagnostics and machine learning in hematology: No high-priority finds today (best candidate scored 0/10)
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
Early cancer detection (liquid biopsy, ctDNA, cfDNA): No high-priority finds today (best candidate scored 7/10)
AI/ML in clinical diagnostics and imaging
AI/ML in clinical diagnostics and imaging: No high-priority finds today (best candidate scored 6/10)
Precision oncology and genomic medicine
43034275 · Antibody-Protein L Functionalized Microparticles for Detection of Surface Markers in Heterogeneous Colorectal Lesions. · 6/10 · We generated heterogeneous CRC tumoroids and orthotopic animal models, expressing both MUC1 and EPCAM, and demonstrated that: (1) APL-MPs identified MUC1- and EPCAM-positive tumoroids in proportion to antigen expression;
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
43035066 · Cemiplimab plus chemotherapy versus chemotherapy in non-small-cell lung cancer with PD-L1 ≥1%: 5-year update of EMPOWER-Lung 3 Part 2 results. · 10/10 · CONCLUSIONS: First-line cemiplimab plus chemotherapy continued to show durable clinical benefit versus placebo plus chemotherapy after 5 years of follow-up in PD-L1-positive advanced NSCLC 43034792 · Efficacy, Safety, and Exploratory Prognostic Factors of TACE-HAIC Plus Lenvatinib with Tislelizumab or Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study. · 8/10 · CONCLUSION: This combination regimen was associated with encouraging outcomes in a selected, high-risk uHCC cohort
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
43035096 · Tirzepatide in Adolescents With Obesity: The SURMOUNT-ADOLESCENTS Randomized Clinical Trial. · 10/10 · CONCLUSIONS AND RELEVANCE: In adolescents with obesity or overweight with obesity-related complications, tirzepatide, in addition to healthy lifestyle intervention, led to significant reductions in percent change in BMI 43034810 · Trimethylamine N-Oxide (TMAO), Inflammation, and Cardiovascular Risk Factors in Adults With Overweight and Obesity: Impact of Fresh Watermelon Consumption in a Randomized Controlled Crossover Trial. · 8/10 · In conclusion, TMAO and selected cardiometabolic risk markers showed favorable within-intervention changes during the watermelon period; however, the between-intervention difference in TMAO was not statistically signific 43034505 · Sodium-glucose cotransporter-2 inhibitor therapy and risk of mortality and morbidity following hospitalization for pneumonia in type 2 diabetes mellitus: An international propensity score-matched cohort study. · 8/10 · CONCLUSION: Patients with T2DM who used SGLT2 inhibitors had significantly lower risks of mortality and morbidity following hospitalization for pneumonia, including a notable reduction in DKA, contrary to prior concerns
Aging, longevity, and population health
Aging, longevity, and population health: No high-priority finds today (best candidate scored 5/10)
Rare diseases with high unmet need
Rare diseases with high unmet need: No high-priority finds today (best candidate scored 0/10)
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
43034335 · Does cemented versus uncemented humeral stem fixation influence outcomes in primary reverse shoulder arthroplasty? An updated systematic review and meta-analysis. · 7/10 · Treatment Innovation 43035245 · Secondary Central Nervous System Lymphoma with Initial Spinal Cord Involvement: Report of One Case. · 6/10 · Treatment Innovation 43035206 · Thickness of the peripapillary retinal nerve fiber layer and its association with disease severity in Parkinson's disease: a cross-sectional case-control study. · 5/10 · Treatment Innovation 43034813 · Atrial Fibrillation During Zanubrutinib Treatment in Chronic Lymphocytic Leukemia With a Historical Ibrutinib Control. · 5/10 · Treatment Innovation 43034804 · Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia: A French Retrospective Observational Study. · 5/10 · Treatment Innovation
CBC-based diagnostics and machine learning in hematology
No retained standard-priority articles.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
43034424 · Unlocking Colorectal Cancer Diagnostics With Circulating Progastrin (hPG80): A Scoping Review. · 7/10 · Early Detection 43035377 · Exhaled Breath Condensate-Derived Extracellular Vesicles Isolated via Nanobody-SpyTag3 Fusion Proteins Enable Lung Cancer Diagnosis. · 6/10 · Early Detection
AI/ML in clinical diagnostics and imaging
43035140 · Cognitive Evaluation of Multimodal Large Language Models in Dental Radiography. · 6/10 · Diagnostics
Precision oncology and genomic medicine
43034424 · Unlocking Colorectal Cancer Diagnostics With Circulating Progastrin (hPG80): A Scoping Review. · 7/10 · Early Detection 43034688 · LKMHCpan: Transformer-optimized HLA-I pseudo-sequences enhance neoantigen prediction for immunotherapy. · 6/10 · Treatment Innovation 43035123 · Targeting Protein Tyrosine Phosphatases in Cancer: Dual Roles and Therapeutic Implications. · 5/10 · Genomics/Precision Medicine 43034980 · Mapping Two Decades of KRAS-Targeted Drug Development in Cancer: A Bibliometric Analysis of Scientific Evolution and Emerging Therapeutic Trends. · 5/10 · Genomics/Precision Medicine 43034718 · Comprehensive characterisation of patients with colorectal cancer and permanently liver-limited disease. · 5/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
43035279 · [Interpreting the 2026 consensus guidance on immune checkpoint inhibitors: evolving landscape of perioperative therapy for locally advanced rectal cancer]. · 7/10 · Treatment Innovation 43035200 · ImmunoPET-guided TIM-3 theranostics enables dynamic visualization of adaptive immune escape and targeted radioimmunotherapy. · 6/10 · Treatment Innovation 43034688 · LKMHCpan: Transformer-optimized HLA-I pseudo-sequences enhance neoantigen prediction for immunotherapy. · 6/10 · Treatment Innovation 43034640 · Real-World Toxicity and Hospitalization Outcomes Following Immunotherapy for Malignant Pleural Mesothelioma. · 5/10 · Treatment Innovation 43034276 · Coupling Autophagic Flux Blockade With Cuproptosis in a Self-Assembled Nanodrug for Osteosarcoma Immunotherapy. · 5/10 · Treatment Innovation
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
43034729 · Apolipoprotein A1 as an emerging cardiovascular biomarker: A systematic review and meta-analysis of its association with cardiovascular outcomes. · 7/10 · Public Health 43034495 · Improving timeliness of antihypertensive treatment intensification through pharmacist-led interventions among older adult patients in Northwest Ethiopia: Multicenter prospective cohort study. · 6/10 · Public Health 43034662 · Central Obesity and Estimated Coronary Heart Disease Risk Among Jordanian Women Aged 30-50 Years: A Framingham Risk Score Analysis. · 5/10 · Public Health 43034633 · Association of GH and IGF-1 Levels with Increased Carotid Intima-Media Thickness and Cardiovascular Risk Scores in Acromegaly: A Cross-Sectional Study. · 5/10 · Public Health 43034521 · Dapagliflozin transfer in breast milk may be clinically insignificant-An opportunity for optimization of evidence-based management of heart failure in postpartum patients. · 5/10 · Public Health
Aging, longevity, and population health
43035371 · Asprosin Promotes Vascular Endothelial Senescence Through STING Pathway Activation Mediated by mtROS-mtDNA Leakage Axis. · 5/10 · Public Health
Rare diseases with high unmet need
No retained standard-priority articles.
💡 UNSOLICITED FINDS
43035387 · Study Design and Baseline Characteristics of APOLLO: A Phase 3 Study of Bitopertin in Erythropoietic Protoporphyria and X-Linked Protoporphyria. · 10/10 · Other 43035281 · [Efficacy and safety of hydromorphone hydrochloride extended-release tablets in patients with moderate-to-severe chronic cancer pain: a multicenter, double-blind, non-inferiority randomized controlled trial]. · 8/10 · Other 43034764 · Effects of graded attentional states on acupuncture sensation: Objective evidence for Deqi from electrooculogram signals in an exploratory randomized controlled trial. · 8/10 · Other 43034755 · Acupuncture for cancer-related fatigue in breast cancer survivors: the AcuBreast study, a pragmatic randomized clinical trial. · 8/10 · Other 43034730 · Positive results in acupuncture randomized controlled trials since 1995: reflections on publications indexed in MEDLINE. · 8/10 · Other 43034728 · Economic evaluation of long-term manual therapy for chronic neck pain: A Markov model-based analysis. · 8/10 · Other 43034695 · Non-Sugar Sweetener Consumption and Glycemic Control in Middle-Aged and Older Adults with Prediabetes: Background, Design, and Methods of a Controlled Feeding Trial. · 8/10 · Other 43034857 · Ultrasound-Guided Versus Blind Corticosteroid Injection for Trigger Finger: A Systematic Review. · 7/10 · Other 43034946 · Age-stratified diagnostic performance of pelvic ultrasound combined with basal LH for differentiating central precocious puberty in girls. · 6/10 · Other
📊 TODAY'S BREAKDOWN
- By research category: Diagnostics: 1, Early Detection: 2, Genomics/Precision Medicine: 4, Other: 9, Public Health: 9, Treatment Innovation: 13
- By evidence maturity: Exploratory: 8, Validated: 30
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 10 reviewed / 6 kept / highest 7
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 2 reviewed / 2 kept / highest 7
- AI/ML in clinical diagnostics and imaging: 3 reviewed / 1 kept / highest 6
- Precision oncology and genomic medicine: 11 reviewed / 6 kept / highest 7
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 7 kept / highest 10
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 11 reviewed / 8 kept / highest 10
- Aging, longevity, and population health: 3 reviewed / 1 kept / highest 5
- Rare diseases with high unmet need: 0 reviewed / 0 kept / highest 0
- Sentinel: 10 reviewed / 9 kept / highest 10
- By source type: peer_reviewed 38 | preprint 0
- Topics with zero 8+ articles this run: CBC-based diagnostics and machine learning in hematology, Early cancer detection (liquid biopsy, ctDNA, cfDNA), AI/ML in clinical diagnostics and imaging, Aging, longevity, and population health, Rare diseases with high unmet need
🔧 RUN NOTES
- The same-day CRDT searches were empty, so the required one-time 48-hour expansion was applied.
- State was stale; the canonical 2026-11-15 run determined the starting checkpoint.
- All capped candidates were reconciled through ESummary and EFetch; no endpoint PMIDs were missing.
- No Telegram alerts were sent by this attempt.